Vulnerabilities

Vulnerability · CVE-2026-27961

Agenta is an open-source LLMOps platform.

Published Feb 26, 2026 · catalog updated Jun 17, 2026 · Agenta is an open-source

Check if you run it

No confirmed exploitation is on record for CVE-2026-27961. EPSS is 0.56%. Act only if a listed version of Agenta is an open-source is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Agenta is an open-source).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High8.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.56%
Remediation
Advisory link
Affected products
cpe agentatech/agenta

Agenta is an open-source LLMOps platform. A Server-Side Template Injection (SSTI) vulnerability exists in versions prior to 0.86.8 in Agenta's API server evaluator template rendering. Although the vulnerable code lives in the SDK package, it is executed server-side within the API process when running evaluators. This does not affect standalone SDK usage — it only impacts self-hosted or managed Agenta platform deployments. Version 0.86.8 contains a fix for the issue.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe agentatech/agentaversion unspecified

How to fix CVE-2026-27961

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-27961. EPSS is 0.56%. Act only if a listed version of Agenta is an open-source is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-1336: Improper Neutralization of Special Elements Used in a Template Engine. EPSS 0.56%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Feb 26, 2026 · NIST NVD

    Detected

    Agenta is an open-source LLMOps platform. A Server-Side Template Injection (SSTI) vulnerability exists in versions prior to 0.86.8 in Agenta's API server evaluator template rendering. Although the vulnerable code lives in the SDK package, it is executed server-side within the API process when running evaluators. This does not affect standalone SDK usage — it only impacts self-hosted or managed Age

  2. Jun 17, 2026 · NIST NVD

    Updated

    Agenta is an open-source LLMOps platform. A Server-Side Template Injection (SSTI) vulnerability exists in versions prior to 0.86.8 in Agenta's API server evaluator template rendering. Although the vulnerable code lives in the SDK package, it is executed server-side within the API process when running evaluators. This does not affect standalone SDK usage — it only impacts self-hosted or managed Age

Sources

  • CVE.orgVulnerability recordCVE-2026-27961

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-27961

    30-day exploitation probability 0.6%

    first.org
  • NIST NVDVulnerability recordCVE-2026-27961

    Agenta is an open-source LLMOps platform. A Server-Side Template Injection (SSTI) vulnerability exists in versions prior to 0.86.8 in Agenta's API server evaluator template rendering. Although the vulnerable code lives in the SDK package, it is executed server-side within the API

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.